Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Revenue: 2009-2024

Historic Revenue for Corcept Therapeutics (CORT) over the last 12 years, with Dec 2024 value amounting to $675.0 million.

  • Corcept Therapeutics' Revenue rose 13.75% to $207.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $741.2 million, marking a year-over-year increase of 17.92%. This contributed to the annual value of $675.0 million for FY2024, which is 39.94% up from last year.
  • According to the latest figures from FY2024, Corcept Therapeutics' Revenue is $675.0 million, which was up 39.94% from $482.4 million recorded in FY2023.
  • Over the past 5 years, Corcept Therapeutics' Revenue peaked at $675.0 million during FY2024, and registered a low of $353.9 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $482.4 million (2023), whereas its average is $519.8 million.
  • Data for Corcept Therapeutics' Revenue shows a peak YoY surged of 39.94% (in 2024) over the last 5 years.
  • Corcept Therapeutics' Revenue (Yearly) stood at $353.9 million in 2020, then climbed by 3.42% to $366.0 million in 2021, then increased by 9.80% to $401.9 million in 2022, then increased by 20.04% to $482.4 million in 2023, then surged by 39.94% to $675.0 million in 2024.